510(k) device
V8 Transluminal BAV Catheter
Intervalve, Inc. · Balloon Aortic Valvuloplasty (OZT, Class II) · First FDA decision Jan 31, 2013, newest Apr 3, 2015Aortic stenosis
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
4
510(k) pathway
Device trials
1
Naming "V8 Transluminal BAV"
MAUDE reports
2
Brand "V8 Transluminal BAV", since 2015
PubMed studies
0
Mentioning "V8 Transluminal BAV"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing V8 Transluminal BAV Catheter
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 4 of 4 decisions filed under this name.
K150343 · Decided Apr 3, 2015 · 51 days after receipt
Device type: Balloon Aortic Valvuloplasty (OZT) · Cardiology
3 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "V8 Transluminal BAV", any status and sponsor, newest update first.
InterValve, Inc.Not on our public-company list
NCT02099942 · 103 participants · Start Mar 2014 · Primary completion Dec 2015
Device: V8 Balloon Aortic Valvuloplasty (BAV) Catheter · For: Aortic Valve Stenosis
Sites: Los Angeles, California; Minneapolis, Minnesota; Nashville, Tennessee · 7 sites in all
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "V8 Transluminal BAV", and for the whole product code for context.
This brand
2 reports: 0 malfunction, 0 injury, 2 death
Whole product code OZT
356 reports: 223 malfunction, 102 injury, 27 death
Newest reports for this brand
3010133561-2015-00002 · Received Sep 30, 2015
Device type: Balloon Aortic Valvuloplasty (OZT)
Device problem as coded: Insufficient Device Problem Information
Patient problem as coded: Death; Aortic Dissection
1 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-1621-2014 · Started Mar 14, 2014 · Posted by FDA May 15, 2014
Reason given: Leak issues were discovered through accelerated age testing.
Cause as FDA categorized it: Nonconforming Material/Component · Device type: Balloon Aortic Valvuloplasty (OZT)
Published research
The most relevant PubMed records for "V8 Transluminal BAV"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code OZT.
- True Flow Valvuloplasty Perfusion CatheterC.R. Bard, Inc. · 510(k) 2017
- ValvuloPro Valvuloplasty Balloon CatheterDongguan TT Medical, Inc. · 510(k) 2024
- KardiaPSI Balloon CatheterIntervention Tech, Inc. · 510(k) 2026
- Valvuloplasty Balloon Catheter (ValvuloPro)Dongguan TT Medical, Inc. · 510(k) 2026
- OutFlo Aortic Valve Dilatation Balloon CatheterDisa Medinotec · 510(k) 2025
- Inoue Balloon aToray Industries, Inc. · 510(k) 2022
- V8 Balloon Aortic Valvuloplasty CatheterIntervalve, Inc. · 510(k) 2015
- True Dilatation Balloon Valvuloplasty CatheterC.R. Bard, Inc. · 510(k) 2015
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.